|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lundgren CI, Hall P, Dickman PW and
Zedenius J: Clinically significant prognostic factors for
differentiated thyroid carcinoma: A population-based, nested
case-control study. Cancer. 106:524–531. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sobin LH: Histological typing of thyroid
tumours. Histopathology. 16:5131990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee J, Song Y and Soh EY: Central lymph
node metastasis is an important prognostic factor in patients with
papillary thyroid microcarcinoma. J Korean Med Sci. 29:48–52. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
American Thyroid Association (ATA)
Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid
Cancer, ; Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL,
Mandel SJ, Mazzaferri EL, McIver B, Pacini F, et al: Revised
American Thyroid Association management guidelines for patients
with thyroid nodules and differentiated thyroid cancer. Thyroid.
19:1167–1214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pfister DG, Spencer S, Brizel DM, Burtness
B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele
DW, et al: Head and neck cancers, Version 2.2014. Clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 12:1454–1487.
2014.PubMed/NCBI
|
|
8
|
Yoshida A: Guidelines for the management
of thyroid tumors. Nihon Geka Gakkai Zasshi. 113:507–601. 2012.(In
Japanese). PubMed/NCBI
|
|
9
|
Teng W, Liu YF, Gao M and Huang G:
Management guidelines for patients with thyroid nodules and
differentiated thyroid cancer. Chin J Clin Oncol. 17:1249–1272.
2012.
|
|
10
|
Chen Q, Zou XH, Wei T, Huang QS, Sun YH
and Zhu JQ: Prediction of ipsilateral and contralateral central
lymph node metastasis in unilateral papillary thyroid carcinoma: A
retrospective study. Gland Surg. 4:288–294. 2015.PubMed/NCBI
|
|
11
|
Kuo EJ, Goffredo P, Sosa JA and Roman SA:
Aggressive variants of papillary thyroid microcarcinoma are
associated with extrathyroidal spread and lymph-node metastases: A
population-level analysis. Thyroid. 23:1305–1311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kebebew E: Heraditary non-medullary
thyroid cancer. World J Surg. 32:678–682. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Y, Chen C, Chen Z, Jiang J, Chen Y,
Jin L, Guo G, Zhang X and Ye T: Prediction of central compartment
lymph node metastasis in papillary thyroid microcarcinoma. Clin
Endocrinol (Oxf). 81:282–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong
SJ, Kim WB and Shong YK: Ultrasonography-guided fine-needle
aspiration of thyroid incidentaloma: Correlation with pathological
findings. Clin Endocrinol (Oxf). 60:21–28. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hay ID, Hutchinson ME, Gonzalez-Losada T,
McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ and Goellner
JR: Papillary thyroid microcarcinoma: A study of 900 cases observed
in a 60-year period. Surgery. 144:980–988. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pisanu A, Reccia I, Nardello O and
Uccheddu A: Risk factors for nodal metastasis and recurrence among
patients with papillary thyroid microcarcinoma: Differences in
clinical relevance between nonincidental and incidental tumors.
World J Surg. 33:460–468. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Usluogullari CA, Onal ED, Ozdemir E, Ucler
R, Kiyak G, Ersoy PE, Yalcin S, Güler G, Ersoy R and Cakir B: A
retrospective analysis of prognostic factors predictive of
lymph-node metastasis and recurrence in thyroid papillary
microcarcinoma. Minerva Endocrinol. 40:15–22. 2015.PubMed/NCBI
|
|
18
|
Giordano D, Gradoni P, Oretti G, Molina E
and Ferri T: Treatment and prognostic factors of papillary thyroid
microcarcinoma. Clin Otolaryngol. 35:118–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garrel R, Tripodi C, Cartier C, Makeieff
M, Crampette L and Guerrier B: Cervical lymphadenopathies signaling
thyroid microcarcinoma. Case study and review of the literature.
Eur Ann Otorhinolaryngol Head Neck Dis. 128:115–119. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Z, Wang L, Yi P, Wang CY and Huang T:
Risk factors for central lymph node metastasis of patients with
papillary thyroid microcarcinoma: A meta-analysis. Int J Clin Exp
Pathol. 7:932–937. 2014.PubMed/NCBI
|
|
21
|
De Pasquale L, Bastagli A, Moro GP and
Ghilardi G: Thyroid microcarcinoma approach: A ten year experience.
Ann Ital Chir. 84:533–539. 2013.PubMed/NCBI
|
|
22
|
Pedrazzini L, Baroli A, Marzoli L,
Guglielmi R and Papini E: Cancer recurrence in papillary thyroid
microcarcinoma: A multivariate analysis on 231 patients with a
12-year follow-up. Minerva Endocrinol. 38:269–279. 2013.PubMed/NCBI
|
|
23
|
Karatzas T, Vasileiadis I, Kapetanakis S,
Karakostas E, Chrousos G and Kouraklis G: Risk factors contributing
to the difference in prognosis for papillary versus micropapillary
thyroid carcinoma. Am J Surg. 206:586–593. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shin HJ, Kim EK, Moon HJ, Yoon JH, Han KH
and Kwak JY: Can increased tumoral vascularity be a quantitative
predicting factor of lymph node metastasis in papillary thyroid
microcarcinoma? Endocrine. 47:273–282. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeng RC, Zhang W, Gao EL, Cheng P, Huang
GL, Zhang XH and Li Q: Number of central lymph node metastasis for
predicting lateral lymph node metastasis in papillary thyroid
microcarcinoma. Head Neck. 36:101–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Khairy GA and Al-Saif A: Incidental
parathyroidectomy during thyroid resection: Incidence, risk
factors, and outcome. Ann Saudi Med. 31:274–278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Choi JS, Kim J, Kwak JY, Kim MJ, Chang HS
and Kim EK: Preoperative staging of papillary thyroid carcinoma:
Comparison of ultrasound imaging and CT. AJR Am J Roentgenol.
193:871–878. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hwang HS and Orloff LA: Efficacy of
preoperative neck ultrasound in the detection of cervical lymph
node metastasis from thyroid cancer. Laryngoscope. 121:487–491.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T,
Miyauchi A, Taniguchi E and Mori I: Loss of cellular
polarity/cohesiveness in the invasive front of papillary thyroid
carcinoma, a novel predictor for lymph node metastasis; possible
morphological indicator of epithelial mesenchymal transition. J
Clin Pathol. 64:325–329. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bai Y, Kakudo K, Li Y, Liu Z, Ozaki T, Ito
Y, Kihara M and Miyauchi A: Subclassification of non-solid-type
papillary thyroid carcinoma identification of high-risk group in
common type. Cancer Sci. 99:1908–1915. 2008.PubMed/NCBI
|
|
31
|
Kakudo K, Tang W, Ito Y, Mori I, Nakamura
Y and Miyauchi A: Papillary carcinoma of the thyroid in Japan:
Subclassification of common type and identification of low risk
group. J Clin Pathol. 57:1041–1046. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang W, Nakamura Y, Zuo H, Yasuoka H, Yang
Q, Wang X, Nakamura M, Mori I, Miyauchi A and Kakudo K:
Differentiation, proliferation and retinoid receptor status of
papillary carcinoma of the thyroid. Pathol Int. 53:204–213. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH
and Lim YC: Predictive factors for ipsilateral or contralateral
central lymph node metastasis in unilateral papillary thyroid
carcinoma. Ann Surg. 249:840–844. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao Q, Ming J, Liu C, Shi L, Xu X, Nie X
and Huang T: Multifocality and total tumor diameter predict central
neck lymph node metastases in papillary thyroid microcarcinoma. Ann
Surg Oncol. 20:746–752. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghossein R, Ganly I, Biagini A, Robenshtok
E, Rivera M and Tuttle RM: Prognostic factors in papillary
microcarcinoma with emphasis on histologic subtyping: A
clinicopathologic study of 148 cases. Thyroid. 24:245–253. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lu ZZ, Zhang Y, Wei SF, Li DS, Zhu QH, Sun
SJ, Li M and Li LI: Outcome of papillary thyroid microcarcinoma:
Study of 1,990 cases. Mol Clin Oncol. 3:672–676. 2015.PubMed/NCBI
|
|
37
|
Handkiewicz-Junak D, Włoch J, Czarniecka
A, Roskosz J, Prokurat A, Pomorski L, Krajewska J, Kropińska A,
Kukulska A and Jarzab B: Completion total thyroidectomy in children
with differentiated thyroid cancer. Endokrynol Pol. 57:356–361.
2006.(In Polish). PubMed/NCBI
|
|
38
|
Kim E, Choi JY, Koo do H, Lee KE and Youn
YK: Differences in the characteristics of papillary thyroid
microcarcinoma ≤5 mm and >5 mm in diameter. Head Neck.
37:694–697. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee HS, Park HS, Kim SW, Choi G, Park HS,
Hong JC, Lee SG, Baek SM and Lee KD: Clinical characteristics of
papillary thyroid microcarcinoma less than or equal to 5 mm on
ultrasonography. Eur Arch Otorhinolaryngol. 270:2969–2974. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
DeLellis RA, Lloyd RV, Heitz PU and Eng C:
World Health Organization Classification of TumoursPathology and
Genetics of Tumours of Endocrine Organs. IARC Press; Lyon: pp.
57–103. 2004
|
|
41
|
Silver CE, Owen RP, Rodrigo JP, Rinaldo A,
Devaney KO and Ferlito A: Aggressive variants of papillary thyroid
carcinoma. Head Neck. 33:1052–1059. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kuo EJ, Goffredo P, Sosa JA and Roman SA:
Aggressive variants of papillary thyroid microcarcinoma are
associated with extrathyroidal spread and lymph-node metastases: A
population-level analysis. Thyroid. 23:1305–1311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chung YS, Kim JY, Bae JS, Song BJ, Kim JS,
Jeon HM, Jeong SS, Kim EK and Park WC: Lateral lymph node
metastasis in papillary thyroid carcinoma: Results of therapeutic
lymph node dissection. Thyroid. 19:241–246. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shindo M, Wu JC, Park EE and Tanzella F:
The importance of central compartment elective lymph node excision
in the staging and treatment of papillary thyroid cancer. Arch
Otolaryngol Head Neck Surg. 132:650–654. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Oh EM, Chung YS, Song WJ and Lee YD: The
pattern and significance of the calcifications of papillary thyroid
microcarcinoma presented in preoperative neck ultrasonography. Ann
Surg Treat Res. 86:115–121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mazeh H, Samet Y, Hochstein D, Mizrahi I,
Ariel I, Eid A and Freund HR: Multifocality in well-differentiated
thyroid carcinomas calls for total thyroidectomy. Am J Surg.
201:770–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sun W, Lan X, Zhang H, Dong W, Wang Z, He
L, Zhang T and Liu S: Risk factors for central lymph node
metastasis in CN0 papillary thyroid carcinoma: A Systematic Review
and Meta-Analysis. PLoS One. 10:e01390212015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chow SM, Law SC, Chan JK, Au SK, Yau S and
Lau WH: Papillary microcarcinoma of the thyroid-prognostic
significance of lymph node metastasis and multifocality. Cancer.
98:31–40. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sánchez-Tilló E, Liu Y, de Barrios O,
Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A
and Postigo A: EMT-activating transcription factors in cancer:
Beyond EMT and tumor invasiveness. Cell Mol Life Sci. 69:3429–3456.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cheng Y and Cu QC: Research advances in
epithelial-mesenchymal transition in thyroid carcinoma. Zhongguo Yi
Xue Ke Xue Yuan Xue Bao. 36:218–222. 2014.(In Chinese). PubMed/NCBI
|
|
52
|
Janda E, Lehmann K, Killisch I, Jechlinger
M, Herzig M, Downward J, Beug H and Grünert S: Ras and TGF[beta]
cooperatively regulate epithelial cell plasticity and metastasis:
Dissection of Ras signaling pathways. J Cell Biol. 156:299–313.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vasko V, Espinosa AV, Scouten W, He H,
Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la
Chapelle A, et al: Gene expression and functional evidence of
epithelial-to-mesenchymal transition in papillary thyroid carcinoma
invasion. Proc Natl Acad Sci USA. 104:2803–2808. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Nakajima S, Doi R, Toyoda E, Tsuji S, Wada
M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, et al: N-cadherin
expression and epithelial-mesenchymal transition in pancreatic
carcinoma. Clin Cancer Res. 10:4125–4133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wada N, Duh QY, Sugino K, Iwasaki H,
Kameyama K, Mimura T, Ito K, Takami H and Takanashi Y: Lymph node
metastasis from 259 papillary thyroid microcarcinomas: Frequency,
pattern of occurrence and recurrence, and optimal strategy for neck
dissection. Ann Surg. 237:399–407. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sakorafas GH, Giotakis J and Stafyla V:
Papillary thyroid microcarcinoma: A surgical perspective. Cancer
Treat Rev. 31:423–438. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
White ML, Gauger PG and Doherty GM:
Central lymph node dissection in differentiated thyroid cancer.
World J Surg. 31:895–904. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ito Y, Jikuzono T, Higashiyama T, Asahi S,
Tomoda C, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K and
Miyauchi A: Clinical significance of lymph node metastasis of
thyroid papillary carcinoma located in one lobe. World J Surg.
30:1821–1828. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lee YS, Kim SW, Kim SW, Kim SK, Kang HS,
Lee ES and Chung KW: Extent of routine central lymph node
dissection with small papillary thyroid carcinoma. World J Surg.
31:1954–1959. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang W, Gu J, Shang J and Wang K:
Correlation analysis on central lymph node metastasis in 276
patients with cN0 papillary thyroid carcinoma. Int J Clin Exp
Pathol. 6:510–515. 2013.PubMed/NCBI
|
|
61
|
Shin HJ, Kim EK, Moon HJ, Yoon JH, Han KH
and Kwak JY: Can increased tumoral vascularity be a quantitative
predicting factor of lymph node metastasis in papillary thyroid
microcarcinoma? Endocrine. 47:273–282. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Park YJ, Kim YA, Lee YJ, Kim SH, Park SY,
Kim KW, Chung JK, Youn YK, Kim KH, Park DJ and Cho BY: Papillary
microcarcinoma in comparison with larger papillary thyroid
carcinoma in BRAF(V600E) mutation, clinicopathological features,
and immunohistochemical findings. Head Neck. 32:38–45.
2010.PubMed/NCBI
|
